Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions
Drug Metabolism and Disposition · 2025
DOI: 10.1124/dmd.123.001384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Robert S Foti. Beteiligte Einrichtung: Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co, Inc, Boston, Massachusetts. Electronic address: robert.foti@merck.com. Hauptthemen laut MEDLINE: Models, Biological, Pharmacokinetics. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 208 Literaturangaben. Gefördert von: Merck & Co Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co, Inc, Boston, Massachusetts. Electronic address: robert.foti@merck.com.
Förderung
- Merck & Co Inc
Zitieren
APA
Foti, R. S. (2025). Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001384
Vancouver
Foti RS. Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions. Drug Metabolism and Disposition. 2025. doi:10.1124/dmd.123.001384
BibTeX
@article{Foti2025,
author = {Foti, Robert S},
title = {Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1124/dmd.123.001384}
}
EUVIMED